Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Mayo Clin Proc. 2013 Aug;88(8):813–821. doi: 10.1016/j.mayocp.2013.05.021

Table 2.

Characteristics of sIgAD/CVID Cases and Their Matched Controls

Variables Case
(n=39)
All
Controls
(n=156)
P value Community
Controls
(n=78)
P value Lab Controls
(n=78)
P value

Male (%) 20 (51.3) 80 (51.3) >.99 40 (51.3) >.99 40 (51.3) >.99

Age at Disease Occur (year)
Mean±SD
Median

34.2±24.2
32.0

34.2±23.9
32.5

.99

34.2±24.0
32.0

>.99

34.2±23.9
33.0

.99

Caucasians (%)§ 33 (97.1) 133 (91.7) .28 65 (91.6) .29 68 (91.9) .31

Educational level (%)
 ≤ High School degree 24 (61.5) 109 (69.9) .33 63 (80.8) .08 46 (59.0) .61
 Some college 4 (10.3) 22 (14.1) 7 (9.0) 15 (19.2)
 College degree 7 (18.0) 14 (9.0) 4 (5.1) 10 (12.8)
 Graduate school degree 4 (10.3) 11 (7.1) 4 (5.1) 7 (9.0)

Asthma prior to index date,
n (%)
9 (23.1) 16 (10.3) .03 7 (9.0) .04 9 (11.5) .10

Asthma ever, n (%) 12 (30.8) 18 (11.5) .01 7 (9.0) .01 11 (14.1) .03

Comorbid conditions 9 (23.1) 18 (11.5) .06 10 (12.8) .16 8 (10.3) .06

SD: standard deviation;

§

: 16 subjects were missed (5 subjects from case, 7 subjects from community control and 4 subjects from lab control);

: Chisquare test for trend; Lab: Controls selected from the Immunology Lab. Database